Apogee Therapeutics Inc — Cash Flow (NASDAQ:APGE) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 74.8 M171.2 M 232.54 M Cash from investing activities 273.91 M300.46 M 62.69 M Cash from financing activities 315.39 M495.11 M 65.9 M Free cash flow 74.63 M170.05 M 227.46 M

News

Jefferies lowers Apogee Therapeutics stock price target on OX40 concerns

Intel, Iris Energy among market cap stock movers on Friday

Intel and AMD among market cap stock movers on Friday

Thursday’s Insider Activity: GameStop CEO’s $21M Buy Stands Out

Apogee Therapeutics stock downgraded by RBC Capital on valuation concerns

Top US Biopharma Stocks Poised for Growth in 2026, According to Deutsche Bank

Apogee Therapeutics CEO Henderson sells $1.6m in stock

Apogee Therapeutics stock hits all-time high at 81.0 USD

Regeneron announcements validate Apogee thesis, says Stifel

Apogee Therapeutics CMO sells $1.45 million in shares

Craig-Hallum raises Apogee Therapeutics stock price target on promising asthma data

UBS initiates Apogee Therapeutics stock with Buy rating, $100 target